Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Agri Lab Leverage currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active prosecution is confined to 1 distinct examiner and 1 distinct art unit, implying that the current workload is not diversified across different USPTO departments. For a practitioner, the strategy for addressing the pending action can be highly specialized for the specific requirements of the 1 distinct art unit involved. This centralized approach allows for a more efficient use of resources when preparing responses.
The busiest examiner for this portfolio is CREWS, JARET JAMES, who is responsible for 1 busiest examiner pending action. Given that the total pending office actions count is 1, CREWS, JARET JAMES is the only examiner currently interacting with the company's pending applications. This creates a streamlined prosecution environment where the practitioner only needs to manage one examiner relationship. The outcome of the current pending matter rests entirely with CREWS, JARET JAMES and the standards of the 1 distinct art unit. This focus allows for a deep analysis of the examiner's past behavior to inform the current strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CREWS, JARET JAMES | 1 | 43.9% | +71.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17602444 | METHOD FOR LOWERING THE OXIDISING POWER OF A LIQUID OR SEMI-LIQUID ORGANIC COMPOSITION | CREWS, JARET JAMES | 16d |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17602444 | METHOD FOR LOWERING THE OXIDISING POWER OF A LIQUID OR SEMI-LIQUID ORGANIC COMPOSITION | CREWS, JARET JAMES | 1691 | §103 | Final Rejection | 16d | Pending | Oct 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAgri Lab Leverage has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jaret James Crews has the most, with 1 of Agri Lab Leverage's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
